buserelin has been researched along with Ovarian Hyperstimulation Syndrome in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 23 (51.11) | 18.2507 |
| 2000's | 11 (24.44) | 29.6817 |
| 2010's | 11 (24.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G | 1 |
| Balayla, J; Dahan, MH; Shrem, G; Son, WY; Steiner, N; Tannus, S; Volodarsky-Perel, A | 1 |
| Ata, B; Dahan, MH; Polat, M; Seyhan, A; Son, WY; Yarali, H | 1 |
| Berglund, L; Hadziosmanovic, N; Holte, J; Huber, M | 1 |
| Birch, H; Datta, AK; Eapen, A; Kurinchi-Selvan, A; Lockwood, G | 1 |
| Barros, A; Cunha, M; Oliveira, C; Silva, J; Sousa, M; Teixeira da Silva, J; Viana, P | 1 |
| Barsoum-Derias, E; Christopoulos, G; El-Shawarby, S; Lavery, S; Trew, G; Vlismas, A | 1 |
| Aramwit, P; Jammeechai, K; Kasettratat, N; Pruksananonda, K | 1 |
| Humaidan, P | 1 |
| Ataie, M; Haghollahi, F; Nasiri, R; Rashidi, B; Tehraninejad, ES | 1 |
| Asada, Y; Endo, T; Hashiba, Y; Honnma, H | 1 |
| Alsbjerg, B; Devroey, P; Fatemi, HM; Humaidan, P; Kyrou, D; Papanikolaou, EG; Polyzos, NP | 1 |
| Barbosa, A; Felgueira, E; Ferreira, C; Figueiredo, H; Osório, M; Pinelo, S; Pinto, E; Pires, I; Serra, H; Tavares, A | 1 |
| Azumaguchi, A; Chida, M; Endo, T; Hayashi, T; Honnma, H; Kamiya, H; Kitajima, Y; Kudo, R; Yamazaki, K | 1 |
| Abyholm, T; Dale, PO; Fedorcsák, P; Storeng, R; Tanbo, T | 1 |
| Makita, S; Oshima, K; Suzuki, K; Yoshida, Y | 1 |
| Calejo, L; Gamboa, C; Martinez-de-Oliveira, J; Nunes, A; Silva, J; Stevenson, D; Xavier, P | 1 |
| Grochowski, D; Kuczyński, W; Kulikowski, M; Szamatowicz, M; Wołczyński, S | 1 |
| Avrech, OM; Fisch, B; Loumaye, E; Neri, A; Ovadia, J; Pinkas, H; Rufas, O | 1 |
| Lieberman, BA; Matson, PL; Troup, SA; Wada, I | 2 |
| De Vits, A; Gerris, J; Joostens, M; Van Royen, E | 1 |
| Caruso, A; Fulghesu, AM; Guida, C; Guido, M; Lanzone, A; Mancuso, S; Nicoletti, MC; Villa, P | 1 |
| Giroud, D; Howles, CM; Loumaye, E; Luyet, G | 1 |
| Feliciani, E; Ferraretti, AP; Fortini, D; Gianaroli, L; Magli, C; Tabanelli, C | 1 |
| Franks, S; Gilling-Smith, C | 1 |
| Gerris, J; Joostens, M; Tas, B; van der Meer, S | 1 |
| Hunt, L; Lieberman, BA; Matson, PL; Morroll, DR; Troup, SA; Wada, I | 1 |
| Casper, RF | 1 |
| Barri, PN; Calderon, G; Coroleu, B; Martinez, F; Traver, JM; Veiga, A | 1 |
| Bergmann, PJ; Camus, M; de Maertelaer, V; Delbaere, A; Deschodt-Lanckman, M; Englert, Y; Gervy-Decoster, C; Staroukine, M | 1 |
| Chatwani, S; Danninger, B; Feichtinger, W; Obruca, A; Strohmer, H; Wieser, F | 1 |
| Itoh, M; Misao, R; Nakanishi, Y; Tamaya, T | 1 |
| Edozien, L; Lieberman, B; Wood, N | 1 |
| Atared, AM; Coskun, S; Hollanders, JM; Jaroudi, KA; Roca, GL | 1 |
| Buckett, WM; Tan, SL | 1 |
| Anderson, H; Braude, P; Khalaf, Y; Taylor, A | 1 |
| Albano, C; Devroey, P; Diedrich, K; Engel, J; Felberbaum, RE; Riethmüller-Winzen, H; Smitz, J | 1 |
| Albano, C; Devroey, P; Diedrich, K; Engel, W; Felberbaum, RE; Ludwig, M; Riethmüller-Winzen, H; Schüler, A | 1 |
| Harada, T; Ito, M; Iwabe, T; Ohata, Y; Terakawa, N; Yoshida, S | 1 |
| Al-Hasani, S; Bauer, O; El-Sheikh, MM; El-Sheikh, R; Fouad, S; Hussein, M | 1 |
| Brinsden, P; Tan, SL | 1 |
| Buck, P; Horne, G; Lieberman, BA; Matson, PL; Wada, I | 1 |
| Buck, P; Hughes, S; Lieberman, BA; Matson, PL; Troup, SA; Wada, I | 1 |
| Bernardus, RE; Hompes, PG; Scheele, F; Schoemaker, J | 1 |
9 review(s) available for buserelin and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate | 2017 |
The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.
Topics: Buserelin; Chorionic Gonadotropin; Clomiphene; Embryo Implantation; Female; Gonadotropin-Releasing Hormone; Humans; Luteal Phase; Luteinizing Hormone; Narcotic Antagonists; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy | 2012 |
Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature.
Topics: Adult; Buserelin; Embryo Transfer; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Term Birth; Treatment Failure | 2012 |
Advances in induction of ovulation.
Topics: Buserelin; Clinical Trials as Topic; Clomiphene; Drug Administration Schedule; Drug Resistance; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Growth Hormone; Humans; Hypogonadism; Naltrexone; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome | 1994 |
Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?
Topics: Buserelin; Chorionic Gonadotropin; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Triptorelin Pamoate | 1996 |
Treatment of polycystic ovary patients undergoing IVF.
Topics: Abortion, Spontaneous; Albumins; Antineoplastic Agents, Hormonal; Buserelin; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Luteinizing Hormone; Menotropins; Oocytes; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Pregnancy | 1997 |
Use of luteinizing hormone releasing hormone agonists in polycystic ovary syndrome.
Topics: Abortion, Habitual; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy | 1998 |
The use of luteinising hormone releasing hormone agonists for ovarian stimulation in assisted reproductive technology.
Topics: Buserelin; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy | 1992 |
Severe ovarian hyperstimulation: a case report and essentials of prevention and management.
Topics: Adult; Buserelin; Female; Humans; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome | 1992 |
15 trial(s) available for buserelin and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.
Topics: Adult; Buserelin; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol-Norgestrel Combination; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Infertility, Female; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Young Adult | 2010 |
Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Cryopreservation; Embryo Transfer; Embryo, Mammalian; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Time Factors | 2002 |
The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial.
Topics: Adult; Buserelin; Cross-Over Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Infertility, Female; Insulin Resistance; Metformin; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Recombinant Proteins | 2003 |
A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Sperm Injections, Intracytoplasmic; Treatment Outcome | 2005 |
Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative study.
Topics: Adolescent; Adult; Buserelin; Chorionic Gonadotropin; Embryo Transfer; Evaluation Studies as Topic; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Follicle Stimulating Hormone, Human; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pituitary Gland, Anterior; Pregnancy; Pregnancy Rate; Recombinant Proteins; Safety; Superovulation; Treatment Outcome | 1995 |
Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Gonadotropins; Humans; Leuprolide; Menotropins; Menstrual Cycle; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Outcome; Radioimmunoassay; Risk Factors | 1995 |
Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin
Topics: Buserelin; Chorionic Gonadotropin; Corpus Luteum Maintenance; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Injections, Intravenous; Luteal Phase; Luteinizing Hormone; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation; Ovulation Induction; Pregnancy; Progesterone | 1995 |
Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study.
Topics: Buserelin; Chorionic Gonadotropin; Embryo Transfer; Estradiol; Europe; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Ovary; Pituitary Gland; Pregnancy; Steroids | 1994 |
Prospective randomized study of D-Trp6-LHRH versus buserelin in long desensitization protocols for medically assisted conception cycles.
Topics: Adult; Buserelin; Delayed-Action Preparations; Down-Regulation; Drug Administration Schedule; Embryonic and Fetal Development; Female; Fertilization in Vitro; Hormones; Humans; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Prospective Studies; Time Factors; Triptorelin Pamoate | 1994 |
Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome.
Topics: Administration, Intranasal; Adult; Buserelin; Female; Humans; Luteinizing Hormone; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Receptors, LHRH; Risk Factors; Secretory Rate | 1993 |
Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation.
Topics: Adult; Angiotensin II; Ascites; Ascitic Fluid; Buserelin; Chromatography, High Pressure Liquid; Estradiol; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Reference Values | 1997 |
Prospective randomized study of an ultrashort gonadotrophin-releasing hormone agonist versus a modified suppression protocol for ovarian stimulation in intracytoplasmic sperm injection cycles.
Topics: Adolescent; Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Humans; Infertility, Male; Male; Microinjections; Middle Aged; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Prospective Studies | 1997 |
Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Embryo Transfer; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Luteinizing Hormone; Oocytes; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Prospective Studies; Treatment Outcome | 2000 |
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.
Topics: Buserelin; Drug Administration Schedule; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Incidence; Ovarian Hyperstimulation Syndrome; Prospective Studies; Reproductive Techniques | 2000 |
Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome.
Topics: Adult; Buserelin; Female; Fertility Agents, Female; Humans; Menotropins; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Reproductive Techniques | 2000 |
21 other study(ies) available for buserelin and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Use of cabergoline and post-collection GnRH antagonist administration for prevention of ovarian hyperstimulation syndrome.
Topics: Adult; Buserelin; Cabergoline; Dopamine Agonists; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Retrospective Studies | 2019 |
Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Cohort Studies; Corpus Luteum; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Quebec; Retrospective Studies; Risk Factors; Severity of Illness Index; Triptorelin Pamoate; Turkey; Ultrasonography | 2013 |
Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Cross-Sectional Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Gonadotropin-Releasing Hormone; Humans; Live Birth; Logistic Models; Nafarelin; Nomograms; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation; Ovulation Induction; Pregnancy; Pregnancy Rate; Recombinant Proteins; Retrospective Studies; Risk Factors; Treatment Outcome | 2013 |
Retrospective comparison of GnRH agonist trigger with HCG trigger in GnRH antagonist cycles in anticipated high-responders.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Cryopreservation; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation; Ovulation Induction; Patient Safety; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Retrospective Studies; Treatment Outcome | 2014 |
Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.
Topics: Buserelin; Chorionic Gonadotropin; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Retrospective Studies | 2015 |
Rescue hCG to treat empty follicle syndrome after the use of a GnRH agonist as oocyte maturation trigger: First report on fresh embryo transfer and clinical pregnancy.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Embryo Transfer; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Infertility, Female; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies | 2015 |
Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization.
Topics: Adult; Ambulatory Care; Buserelin; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropins; Humans; Observation; Ovarian Hyperstimulation Syndrome; Prospective Studies; Risk Factors; Thailand; Urofollitropin | 2008 |
Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Drug Combinations; Female; Gonadotropin-Releasing Hormone; Humans; Luteal Phase; Ovarian Hyperstimulation Syndrome; Pilot Projects; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted | 2009 |
Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Embryo Transfer; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Oocytes; Oogenesis; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Treatment Failure | 2011 |
Treatment with buserelin, an agonist of gonadotropin-releasing hormone, suppresses ovarian hyperstimulation syndrome induced in rabbits.
Topics: Animals; Ascites; Buserelin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Menotropins; Organ Size; Ovarian Hyperstimulation Syndrome; Ovary; Progesterone; Rabbits; Uterus | 2004 |
Use of GnRH analog for induction of the ovulatory surge of gonadotropins in patients at risk of the ovarian hyperstimulation syndrome.
Topics: Buserelin; Chorionic Gonadotropin; Clomiphene; Embryo Transfer; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Menotropins; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Risk Factors | 1995 |
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Progesterone; Prospective Studies | 1994 |
Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition?
Topics: Adult; Buserelin; Cryopreservation; Embryo, Mammalian; Estradiol; Female; Fertilization in Vitro; Gamete Intrafallopian Transfer; Gonadotropin-Releasing Hormone; Humans; Incidence; Infertility, Female; Middle Aged; Ovarian Hyperstimulation Syndrome; Pregnancy; Risk Factors; Triptorelin Pamoate | 1993 |
Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Gamete Intrafallopian Transfer; Humans; Infertility, Female; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Risk Factors | 1993 |
Direct intraperitoneal insemination in ovarian hyperstimulation cycles induced with gonadotropin-releasing hormone agonist.
Topics: Adult; Buserelin; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Insemination, Artificial, Homologous; Male; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Superovulation; Treatment Outcome | 1997 |
Symptomatic unilateral pleural effusion as a presentation of ovarian hyperstimulation syndrome.
Topics: Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Humans; Infertility, Male; Male; Menotropins; Ovarian Hyperstimulation Syndrome; Pleural Effusion | 1998 |
Recovery and maturation of immature oocytes in patients at risk for ovarian hyperstimulation syndrome.
Topics: Antineoplastic Agents, Hormonal; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Granulosa Cells; Humans; Infertility, Female; Infertility, Male; Leuprolide; Male; Menstrual Cycle; Oocytes; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Risk Factors | 1998 |
Two rare events in one patient undergoing assisted conception: empty follicle syndrome and ovarian hyperstimulation with the sole administration of a gonadotropin-releasing hormone agonist.
Topics: Adult; Buserelin; Female; Humans; Infertility, Female; Infertility, Male; Male; Oocytes; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Sperm Injections, Intracytoplasmic | 2000 |
Limited ovarian stimulation (LOS), prevents the recurrence of severe forms of ovarian hyperstimulation syndrome in polycystic ovarian disease.
Topics: Administration, Intranasal; Adult; Buserelin; Cell Count; Chorionic Gonadotropin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Humans; Infertility, Female; Oocytes; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Prospective Studies; Recurrence; Specimen Handling; Time Factors | 2001 |
Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome?
Topics: Adult; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Humans; Luteinizing Hormone; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction | 1992 |
Outcome of treatment subsequent to the elective cryopreservation of all embryos from women at risk of the ovarian hyperstimulation syndrome.
Topics: Buserelin; Cell Survival; Cryopreservation; Embryo Implantation; Embryo, Mammalian; Estradiol; Female; Humans; Luteal Phase; Oocytes; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Outcome; Progesterone; Risk Factors; Treatment Outcome | 1992 |